Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01849796 · ClinicalTrials.gov registry record · Phase 2
Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain
A Phase 2 study, sponsored by Beth Israel Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT01849796 is a Phase 2 study that was terminated before completion, run by Beth Israel Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT01849796, a Phase 2 study, was terminated before completion, sponsored by Beth Israel Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
A study to determine if transcranial direct current stimulation (tDCS, the device that regulates brain activity, can improve pain in people with neuropathic facial pain and compare which modality (inhibitory tDCS over the somatosensory cortex or excitatory tDCS over the motor cortex) can result in better pain-relief.)
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01849796
The ClinicalTrials.gov registry entry for NCT01849796 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT01849796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01849796 about?
NCT01849796 is a clinical study titled "Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain". A study to determine if transcranial direct current stimulation (tDCS, the device that regulates brain activity, can improve pain in people with neuropathic facial pain and compare which modality (inhibitory tDCS over the somatosensory cortex or excitatory tDCS over the motor cortex) can result in b...
What is the current status of trial NCT01849796?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2010-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01849796?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT01849796?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.